Britt Lisa P.'s Form 4 filing
Thermo Fisher Scientific Inc. (TMO) · filed Sep 1, 2026
- Accession no.
- 0000097745-26-000161
- Filed
- Sep 1, 2026, 4:10 PM ET
- Trade date
- Aug 28, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Britt Lisa P.CIK 0001676320 | Officer (Sr. VP and Chief HR Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 28, 2026 | Common Stock | FTax withholdingDisposed | −87.03 | $622.18 | −$54,148.33 | 14,697.118 | Direct | |
| Aug 28, 2026 | Common Stock | FTax withholdingDisposed | −116.04 | $622.18 | −$72,197.77 | 14,581.078 | Direct | |
| Aug 28, 2026 | Common Stock | FTax withholdingDisposed | −105.403 | $622.18 | −$65,579.64 | 14,475.675 | Direct | |
| Aug 28, 2026 | Common Stock | FTax withholdingDisposed | −85.096 | $622.18 | −$52,945.03 | 14,390.579 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.